Table 2 Detailed Availability of the surveyed antibacterial in different levels of hospitals
From: The availability, price and affordability of essential antibacterials in Hubei province, China
Number | Medicine | LEML | Total Availability | Availability in Primary Hospitals | Availability in Secondary Hospitals | Availability in Tertiary Hospitals | ||||
|---|---|---|---|---|---|---|---|---|---|---|
OBs | LPGs | OBs | LPGs | OBs | LPGs | OBs | LPGs | |||
1 | Amoxicillin/Clavulanic Acid | Y | 0.0% | 84.8% | 0.0% | 100.0% | 0.0% | 76.9% | 0.0% | 77.8% |
2 | Ampicillin | Y | 0.0% | 24.2% | 0.0% | 45.5% | 0.0% | 15.4% | 0.0% | 11.1% |
3 | Ceftriaxone | Y | 12.1% | 75.8% | 0.0% | 90.9% | 7.7% | 53.8% | 33.3% | 88.9% |
4 | Ceftazidime | Y | 3.0% | 69.7% | 0.0% | 36.4% | 0.0% | 84.6% | 11.1% | 88.9% |
5 | Chloramphenicol | N | – | 3.0% | – | 0.0% | – | 0.0% | – | 11.1% |
6 | Ciprofloxacin | Y | 3.0% | 18.2% | 0.0% | 18.2% | 0.0% | 15.4% | 11.1% | 22.2% |
7 | Nitrofurantoin | N | – | 30.3% | – | 27.3% | – | 30.8% | – | 33.3% |
8 | Cephalexin | Y | 0.0% | 33.3% | 0.0% | 18.2% | 0.0% | 30.8% | 0.0% | 55.6% |
9 | Gentamicin Sulfate | N | – | 87.9% | – | 90.9% | – | 76.9% | – | 100.0% |
10 | Norfloxacin | N | – | 69.7% | – | 36.4% | – | 84.6% | – | 88.9% |
11 | Metronidazole | Y | – | 78.8% | – | 54.5% | – | 84.6% | – | 100.0% |
12 | Piperacillin+Tazobactam | Y | – | 21.2% | – | 18.2% | – | 7.7% | – | 44.4% |
13 | Cefaclor | Y | 18.2% | 33.3% | 18.2% | 45.5% | 0.0% | 38.5% | 44.4% | 11.1% |
14 | Roxithromycin | Y | 0.0% | 60.6% | 0.0% | 63.6% | 0.0% | 53.8% | 0.0% | 66.7% |
15 | Furazolidone | N | – | 27.3% | – | 18.2% | – | 23.1% | – | 44.4% |
16 | Linezolid | N | 3.0% | – | 0.0% | – | 0.0% | – | 11.1% | – |
Median | 3.0% | 33.3% | – | 36.4% | – | 34.7% | 11.1% | 50.0% | ||